Skip to search.
 TSX Up 1.59% TSX Ventures Down 0.37%

Sanofi (SNY)

-NYSE
52.64 Down 1.17(2.17%) Jul 29, 4:03PM EDT
Add to Portfolio
Prev Close:53.81
Open:53.74
Bid:53.92 x 3000
Ask:53.99 x 5900
1y Target Est:57.50
Beta:0.83
Next Earnings Date:N/A
Day's Range:52.64 - 54.04
52wk Range:43.57 - 57.42
Volume:1,294,727
Avg Vol (3m):1,680,190
Market Cap:137.65B
P/E (ttm):29.39
EPS (ttm):1.79
Div & Yield:1.61 (3.00%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNYDown 2.17%137.65B
GSKUp 2.18%102.93B
MRKUp 1.77%165.39B
PFEUp 1.16%220.20B

Key Statistics

Forward P/E (1 yr):16.30
P/S (ttm):3.65
Ex-Dividend Date:06-May-15

Analysts

Annual EPS Est (Dec-15) :3.17
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):2.04

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sanofi researches, develops, and markets various therapeutic solutions. Its products comprise diabetes solutions, including Lantus, Apidra, and Insuman that are human insulin analogs; Amaryl, an oral sulfonylurea; Lyxumia, a glucagon-like peptide-... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback